Authors: Sabb, AL Vogel, RL Kelly, MG Palmer, Y Smith, DL Andree, TH Schechter, LE

Citation: Al. Sabb et al., 1,2,5-thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors, BIOORG MED, 11(8), 2001, pp. 1069-1071

Authors: Welmaker, GS Nelson, JA Sabalski, JE Sabb, AL Potoski, JR Graziano, D Kagan, M Coupet, J Dunlop, J Mazandarani, H Rosenzweig-Lipson, S Sukoff, S Zhang, YX

Citation: Gs. Welmaker et al., Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines, BIOORG MED, 10(17), 2000, pp. 1991-1994

Authors: Bartolomeo, AC Morris, H Buccafusco, JJ Kille, N Rosenzweig-Lipson, S Husbands, MG Sabb, AL Abou-Gharbia, M Moyer, JA Boast, CA

Citation: Ac. Bartolomeo et al., The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist, J PHARM EXP, 292(2), 2000, pp. 584-596

Authors: Sabb, AL Husbands, GM Tokolics, J Stein, RP Tasse, RP Boast, CA Moyer, JA Abou-Gharbia, M

Citation: Al. Sabb et al., Discovery of a highly potent, functionally-selective muscarinic M-1 agonist,WAY-132983 using rational drug design and receptor modelling, BIOORG MED, 9(14), 1999, pp. 1895-1900